BR0211156A - Forma de dosagem de liberação controlada com taxas de liberação variáveis - Google Patents
Forma de dosagem de liberação controlada com taxas de liberação variáveisInfo
- Publication number
- BR0211156A BR0211156A BR0211156-0A BR0211156A BR0211156A BR 0211156 A BR0211156 A BR 0211156A BR 0211156 A BR0211156 A BR 0211156A BR 0211156 A BR0211156 A BR 0211156A
- Authority
- BR
- Brazil
- Prior art keywords
- dosage form
- layer
- tablet core
- controlled release
- varying
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"FORMA DE DOSAGEM DE LIBERAçãO CONTROLADA COM TAXAS DE LIBERAçãO VARIáVEIS". Uma forma de dosagem de liberação controlada com taxas de liberação variáveis compreendendo: 1) um núcleo do comprimido de camada dupla ou de camada múltipla e que pelo menos uma das camadas contém um ou mais ingredientes farmaceuticamente ativos e pelo menos uma das camadas contém um ou mais polímeros controladores de taxa; 2) uma cobertura substancialmente insolúvel estendida sobre o núcleo do comprimido cobrindo a maior parte da superfície do comprimido mas deixando uma porção de uma camada do núcleo do comprimido exposta (camada exposta), a cobertura resultando da deposição eletrostática de um pó compreendendo partículas fundíveis sobre o núcleo do comprimido e fundindo-se as partículas para formar uma película fina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0117618.9A GB0117618D0 (en) | 2001-07-19 | 2001-07-19 | Pharmaceutical dosage form |
PCT/GB2002/003286 WO2003007919A1 (en) | 2001-07-19 | 2002-07-18 | Controlled drug delivery systems providing variable release rates |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0211156A true BR0211156A (pt) | 2004-08-10 |
Family
ID=9918808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0211156-0A BR0211156A (pt) | 2001-07-19 | 2002-07-18 | Forma de dosagem de liberação controlada com taxas de liberação variáveis |
Country Status (14)
Country | Link |
---|---|
US (1) | US20060099257A1 (pt) |
EP (1) | EP1406597A1 (pt) |
JP (2) | JP2005519858A (pt) |
KR (1) | KR20040032857A (pt) |
CN (1) | CN1556697A (pt) |
AU (1) | AU2002317360B2 (pt) |
BR (1) | BR0211156A (pt) |
CA (1) | CA2457308A1 (pt) |
GB (1) | GB0117618D0 (pt) |
IL (1) | IL159876A0 (pt) |
MX (1) | MXPA04000544A (pt) |
RU (1) | RU2004104950A (pt) |
WO (1) | WO2003007919A1 (pt) |
ZA (1) | ZA200401216B (pt) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1487417A4 (en) | 2001-09-17 | 2010-03-17 | Glaxo Group Ltd | DRY POWDER DRUG FORMULATIONS |
AR045330A1 (es) * | 2003-08-07 | 2005-10-26 | Sb Pharmco Inc | Forma de dosificacion oral, procedimiento para su preparacion y uso del compuesto 5-(4-(2-(n-metil-n- (2-piridil)amino)etoxi )bencil) tiazolidin-2,4-diona o una sal o solvato farmaceuticamente aceptable del mismo para prepararla |
US8153159B2 (en) | 2003-09-18 | 2012-04-10 | Cephalon, Inc. | Modafinil modified release pharmaceutical compositions |
WO2005030181A1 (en) * | 2003-09-26 | 2005-04-07 | Alza Corporation | Controlled release formulations of opioid and nonopioid analgesics |
KR20060115860A (ko) * | 2003-09-26 | 2006-11-10 | 알자 코포레이션 | 활성 제제의 서방성 전달을 위한 oros 푸시-스틱 |
WO2005030182A1 (en) * | 2003-09-26 | 2005-04-07 | Alza Corporation | Controlled release formulations exhibiting an ascending rate of release |
WO2005072079A2 (en) * | 2003-09-26 | 2005-08-11 | Alza Coporation | Drug coating providing high drug loading and methods for providing the same |
US7553377B1 (en) | 2004-04-27 | 2009-06-30 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for electrostatic coating of an abluminal stent surface |
US7390524B1 (en) | 2004-05-20 | 2008-06-24 | Advanced Cardiovascular Systems, Inc. | Method for electrostatic spraying of an abluminal stent surface |
ATE401868T1 (de) * | 2004-08-04 | 2008-08-15 | Alza Corp | ZUSAMMENSETZUNG MIT VERZÖGERTER ARZNEIMITTELFREISETZUNG MIT EINEM AUFSTEIGENDEN NULLORDNUNG-FREIGABE-MUSTER; VERFAHREN ZUR HERSTELLUNG EINER SOLCHEN ZUSAMMENSETZUNGß |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
DK1836665T3 (da) | 2004-11-19 | 2013-04-15 | Glaxosmithkline Llc | Fremgangsmåde til specialtilpasset afgivelse af medikamentkombinationsprodukter med variabel dosis til individualisering af terapier |
US20070259930A1 (en) * | 2006-04-10 | 2007-11-08 | Knopp Neurosciences, Inc. | Compositions and methods of using r(+) pramipexole |
US8518926B2 (en) | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
KR20090021169A (ko) | 2006-05-16 | 2009-02-27 | 크놉 뉴로사이언시스 인코포레이티드 | R(+) 및 s(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법 |
EP2465500A1 (en) | 2006-05-16 | 2012-06-20 | Knopp Neurosciences, Inc. | Therapeutically effective amounts of R(+) and S(-) pramipexole for use in the treatment of parkinson's disease |
JP5410964B2 (ja) * | 2006-05-23 | 2014-02-05 | オラヘルス コーポレーション | 付着性アカシアゴムを含む二層構造の口腔内付着錠 |
US8524695B2 (en) * | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
WO2008113056A2 (en) | 2007-03-14 | 2008-09-18 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
JP2011512349A (ja) * | 2008-02-15 | 2011-04-21 | サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッド | 経口放出制御錠剤 |
TWI542338B (zh) * | 2008-05-07 | 2016-07-21 | 壯生和壯生視覺關懷公司 | 用於活性劑之控制釋放的眼用裝置 |
US8343524B2 (en) | 2008-07-31 | 2013-01-01 | Clarke Mosquito Control Products, Inc. | Extended release tablet and method for making and using same |
US20110142905A1 (en) * | 2008-08-14 | 2011-06-16 | Bioneer A/S | Coated tablets with remaining degradation surface over the time |
EP2334185A4 (en) * | 2008-08-19 | 2011-09-21 | Knopp Neurosciences Inc | COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL |
TWI478712B (zh) | 2008-09-30 | 2015-04-01 | Astellas Pharma Inc | 釋控性醫藥組成物 |
MX2011013577A (es) * | 2009-06-19 | 2012-04-10 | Knopp Neurosciences Inc | Composiciones y metodos para tratar esclerosis lateral amiotrofica. |
WO2011122524A1 (ja) | 2010-03-29 | 2011-10-06 | アステラス製薬株式会社 | 放出制御医薬組成物 |
EP2481411A1 (en) * | 2011-01-27 | 2012-08-01 | Ratiopharm GmbH | Oral dosage forms for modified release comprising the JAK3 inhibitor tasocitinib |
LT5850B (lt) | 2011-08-31 | 2012-07-25 | Česlovas Paplauskas | Vertikalaus srauto išorinis fazės apgręžiklis garso monitoriams |
US9597425B2 (en) * | 2011-10-18 | 2017-03-21 | St. Teresa Medical, Inc. | Method of forming a hemostatic product |
CA2859174C (en) | 2011-12-12 | 2019-03-05 | Orbis Biosciences, Inc. | Sustained release particle formulations |
WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
PL3019167T3 (pl) | 2013-07-12 | 2021-06-14 | Knopp Biosciences Llc | Leczenie podwyższonych poziomów eozynofili i/lub bazofili |
US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
HUE055850T2 (hu) | 2013-08-13 | 2022-01-28 | Knopp Biosciences Llc | Készítmények és módszerek a krónikus urticaria (csalánkiütés) kezelésére |
ES2813674T3 (es) | 2013-08-13 | 2021-03-24 | Knopp Biosciences Llc | Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b |
WO2015117004A1 (en) * | 2014-01-31 | 2015-08-06 | Board Of Regents, The University Of Texas System | Method for preparing films |
CN115645374B (zh) * | 2022-12-25 | 2024-04-26 | 山东理工职业学院 | 一种硫酸沙丁胺醇片的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8820353D0 (en) * | 1988-08-26 | 1988-09-28 | Staniforth J N | Controlled release tablet |
DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
GB2253164B (en) * | 1991-02-22 | 1994-10-05 | Hoechst Uk Ltd | Improvements in or relating to electrostatic coating of substrates of medicinal products |
IT1264696B1 (it) * | 1993-07-09 | 1996-10-04 | Applied Pharma Res | Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata |
GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
HUP9901981A3 (en) * | 1995-05-09 | 2000-06-28 | Colorcon Ltd Dartford | Powder coating composition for electrostatic coating of pharmaceutical substrates |
NL1014915C2 (nl) * | 1999-04-13 | 2001-02-12 | Beecham Pharm Pte Ltd | Nieuwe behandelingsmethode. |
-
2001
- 2001-07-19 GB GBGB0117618.9A patent/GB0117618D0/en not_active Ceased
-
2002
- 2002-07-18 MX MXPA04000544A patent/MXPA04000544A/es unknown
- 2002-07-18 BR BR0211156-0A patent/BR0211156A/pt not_active Application Discontinuation
- 2002-07-18 CA CA002457308A patent/CA2457308A1/en not_active Abandoned
- 2002-07-18 EP EP02745646A patent/EP1406597A1/en not_active Withdrawn
- 2002-07-18 AU AU2002317360A patent/AU2002317360B2/en not_active Ceased
- 2002-07-18 IL IL15987602A patent/IL159876A0/xx unknown
- 2002-07-18 CN CNA028184734A patent/CN1556697A/zh active Pending
- 2002-07-18 KR KR10-2004-7000801A patent/KR20040032857A/ko not_active Application Discontinuation
- 2002-07-18 JP JP2003513528D patent/JP2005519858A/ja active Pending
- 2002-07-18 RU RU2004104950/15A patent/RU2004104950A/ru not_active Application Discontinuation
- 2002-07-18 JP JP2003513528A patent/JP2005501039A/ja active Pending
- 2002-07-18 US US10/484,734 patent/US20060099257A1/en not_active Abandoned
- 2002-07-18 WO PCT/GB2002/003286 patent/WO2003007919A1/en active Application Filing
-
2004
- 2004-02-16 ZA ZA200401216A patent/ZA200401216B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL159876A0 (en) | 2004-06-20 |
JP2005519858A (ja) | 2005-07-07 |
WO2003007919A1 (en) | 2003-01-30 |
EP1406597A1 (en) | 2004-04-14 |
KR20040032857A (ko) | 2004-04-17 |
CN1556697A (zh) | 2004-12-22 |
RU2004104950A (ru) | 2005-03-10 |
MXPA04000544A (es) | 2005-06-06 |
AU2002317360B2 (en) | 2006-08-17 |
ZA200401216B (en) | 2005-03-17 |
US20060099257A1 (en) | 2006-05-11 |
JP2005501039A (ja) | 2005-01-13 |
GB0117618D0 (en) | 2001-09-12 |
CA2457308A1 (en) | 2003-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0211156A (pt) | Forma de dosagem de liberação controlada com taxas de liberação variáveis | |
BR0211157A (pt) | Forma de dosagem de liberação controlada | |
ATE233604T1 (de) | Elektrostatische beschichtung | |
CA2145513A1 (en) | Pharmaceutical Tablet Capable of Liberating One or More Drugs at Different Release Rates | |
ATE271377T1 (de) | Arzneimittelform mit zwei überzugs-schichten | |
BR9807368A (pt) | Comprimidos de oxacarvazepina revestidos com pelìcula | |
ATE433669T1 (de) | Tablettenförmiges süsswarenprodukt mit dreifachbeschichtung | |
ATE219165T1 (de) | Film- oder schicht-abscheidung und pulver herstellung | |
DE60237372D1 (de) | Magenretentionssystem mit kontrollierter arzneimittelfreisetzung | |
EP1449641A4 (en) | COATED COATED ARTICLES AND THESE USE OF COATED FUNCTIONAL ARTICLES COATED WITH COATING COATINGS | |
DE60336671D1 (de) | Dosierform mit einem innenkern und mindestens zwei bezugsschichten | |
BR0312445A (pt) | Sistemas multiunitários para disponibilização de fármaco de liberação modificada | |
GB0204772D0 (en) | Pharmaceutical dosage forms | |
ATE251449T1 (de) | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe | |
BR0315142A (pt) | Cápsula, tablete, grânulo ou grânulo fino, e, cápsula de liberação prolongada | |
DE60138428D1 (de) | Oralen Arzneiform mit Oeffnungen in der äusseren Hülle | |
MX9203168A (es) | Substrato provisto de multiples capas, procedimiento para la formacion de dichas capas y composicion de revestimiento. | |
GB2316086A (en) | Powder coating composition for electrostatic coating of pharmaceutical substrates | |
AU2001289126A1 (en) | Metered dose inhaler can coated two or more times with fluorocarbon polymers | |
AR036998A1 (es) | Composiciones formadoras de peliculas, formas de dosificacion farmaceuticas y medicamento en forma de imitacion de capsula que las comprenden, un metodo para mejorar la uniformidad del color de una capa de la composicion de revestimiento y un metodo para incrementar el aumento de peso de una capa de | |
TW200628529A (en) | Inorganic material film, inorganic material film structure, the process of manufacture them and a transfer film | |
ATE195871T1 (de) | Steroid enthaltende dosierungsformen mit einer steroiddichten umhüllung | |
WO2000056266A3 (en) | Taste masking coating compositions | |
BR0115206A (pt) | Composições hidroliticamente instáveis | |
JPS52123426A (en) | Composition for forming coating layer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |